InsiderClue
Insiders · Profile

GADICKE ANSBERT

10% owner at Aktis Oncology · Former 10% Owner at Werewolf Therapeutics · Director at Cullinan Therapeutics · and 1 more. Filing since 1 Feb 2012. CIK 0001134655

AKTS Aktis Oncology, Inc. 10% owner · 1 trade HOWL Werewolf Therapeutics, Inc. Former 10% Owner · 30 trades CGEM Cullinan Therapeutics, Inc. Director · 37 trades VSTM Verastem, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
AKTS Aktis Oncology, Inc.
12 Jan 2026
10% owner
Bought
1,112,777
$20.03M
12.2%
HOWL Werewolf Therapeutics, Inc.
4 Dec 2025
Former 10% Owner
Sold on a plan
83,230
$80.73K
1.7%
HOWL Werewolf Therapeutics, Inc.
3 Dec 2025
Former 10% Owner
Sold on a plan
57,225
$49.79K
1.2%
HOWL Werewolf Therapeutics, Inc.
2 Dec 2025
Former 10% Owner
Sold on a plan
59,277
$52.76K
1.2%
HOWL Werewolf Therapeutics, Inc.
1 Dec 2025
10% owner
Sold on a plan
60,917
$57.26K
1.2%
HOWL Werewolf Therapeutics, Inc.
28 Nov 2025
10% owner
Sold on a plan
20,277
$20.07K
0.4%
HOWL Werewolf Therapeutics, Inc.
26 Nov 2025
10% owner
Sold on a plan
60,733
$59.52K
1.2%
HOWL Werewolf Therapeutics, Inc.
25 Nov 2025
10% owner
Sold on a plan
42,533
$39.13K
0.8%
HOWL Werewolf Therapeutics, Inc.
24 Nov 2025
10% owner
Sold on a plan
88,802
$87.03K
1.7%
HOWL Werewolf Therapeutics, Inc.
21 Nov 2025
10% owner
Sold on a plan
64,331
$53.39K
1.2%
HOWL Werewolf Therapeutics, Inc.
20 Nov 2025
10% owner
Sold on a plan
41,152
$36.63K
0.8%
HOWL Werewolf Therapeutics, Inc.
19 Nov 2025
10% owner
Sold on a plan
66,324
$62.34K
1.2%
HOWL Werewolf Therapeutics, Inc.
18 Nov 2025
10% owner
Sold on a plan
52,627
$48.94K
1.0%
HOWL Werewolf Therapeutics, Inc.
17 Nov 2025
10% owner
Sold on a plan
57,061
$54.21K
1.0%
HOWL Werewolf Therapeutics, Inc.
14 Nov 2025
10% owner
Sold on a plan
61,640
$57.33K
1.1%
HOWL Werewolf Therapeutics, Inc.
13 Nov 2025
10% owner
Sold on a plan
90,951
$89.13K
1.6%
HOWL Werewolf Therapeutics, Inc.
12 Nov 2025
10% owner
Sold on a plan
40,669
$44.33K
0.7%
HOWL Werewolf Therapeutics, Inc.
11 Nov 2025
10% owner
Sold on a plan
55,810
$63.62K
1.0%
HOWL Werewolf Therapeutics, Inc.
10 Nov 2025
10% owner
Sold on a plan
48,570
$57.31K
0.8%
HOWL Werewolf Therapeutics, Inc.
7 Nov 2025
10% owner
Sold on a plan
68,480
$76.01K
1.2%
HOWL Werewolf Therapeutics, Inc.
6 Nov 2025
10% owner
Sold on a plan
54,452
$65.89K
0.9%
HOWL Werewolf Therapeutics, Inc.
5 Nov 2025
10% owner
Sold on a plan
47,950
$58.50K
0.8%
HOWL Werewolf Therapeutics, Inc.
4 Nov 2025
10% owner
Sold on a plan
140,488
$171.40K
2.3%
HOWL Werewolf Therapeutics, Inc.
3 Nov 2025
10% owner
Sold on a plan
94,063
$121.34K
1.5%
HOWL Werewolf Therapeutics, Inc.
31 Oct 2025
10% owner
Sold on a plan
114,044
$145.98K
1.8%
HOWL Werewolf Therapeutics, Inc.
30 Oct 2025
10% owner
Sold on a plan
86,936
$124.32K
1.3%
HOWL Werewolf Therapeutics, Inc.
29 Oct 2025
10% owner
Sold on a plan
134,240
$208.07K
2.0%
HOWL Werewolf Therapeutics, Inc.
28 Oct 2025
10% owner
Sold on a plan
69,068
$113.27K
1.0%
HOWL Werewolf Therapeutics, Inc.
27 Oct 2025
10% owner
Sold on a plan
72,709
$125.06K
1.1%
HOWL Werewolf Therapeutics, Inc.
27 Mar 2025
10% owner
Sold at will
4,386
$4.61K
0.1%
CGEM Cullinan Therapeutics, Inc.
16 Sep 2021
Director
Sold, plan not stated
3,124
$90.78K
0.0%
CGEM Cullinan Therapeutics, Inc.
16 Sep 2021
Director
Sold, plan not stated
432
$12.55K
0.2%
CGEM Cullinan Therapeutics, Inc.
15 Sep 2021
Director
Sold, plan not stated
6,425
$187.35K
0.1%
CGEM Cullinan Therapeutics, Inc.
15 Sep 2021
Director
Sold, plan not stated
888
$25.89K
0.4%
CGEM Cullinan Therapeutics, Inc.
14 Sep 2021
Director
Sold, plan not stated
7,106
$207.28K
0.1%
CGEM Cullinan Therapeutics, Inc.
14 Sep 2021
Director
Sold, plan not stated
982
$28.64K
0.4%
CGEM Cullinan Therapeutics, Inc.
13 Sep 2021
Director
Sold, plan not stated
3,595
$104.61K
0.0%
CGEM Cullinan Therapeutics, Inc.
13 Sep 2021
Director
Sold, plan not stated
497
$14.46K
0.2%
CGEM Cullinan Therapeutics, Inc.
10 Sep 2021
Director
Sold, plan not stated
5,931
$172.24K
0.1%
CGEM Cullinan Therapeutics, Inc.
10 Sep 2021
Director
Sold, plan not stated
820
$23.81K
0.3%
CGEM Cullinan Therapeutics, Inc.
9 Sep 2021
Director
Sold, plan not stated
13,727
$402.89K
0.2%
CGEM Cullinan Therapeutics, Inc.
9 Sep 2021
Director
Sold, plan not stated
1,898
$55.71K
0.8%
CGEM Cullinan Therapeutics, Inc.
8 Sep 2021
Director
Sold, plan not stated
10,842
$315.61K
0.1%
CGEM Cullinan Therapeutics, Inc.
8 Sep 2021
Director
Sold, plan not stated
1,499
$43.64K
0.6%
CGEM Cullinan Therapeutics, Inc.
7 Sep 2021
Director
Sold, plan not stated
25,067
$727.95K
0.3%
CGEM Cullinan Therapeutics, Inc.
7 Sep 2021
Director
Sold, plan not stated
3,465
$100.62K
1.4%
CGEM Cullinan Therapeutics, Inc.
3 Sep 2021
Director
Sold, plan not stated
12,731
$376.84K
0.2%
CGEM Cullinan Therapeutics, Inc.
3 Sep 2021
Director
Sold, plan not stated
1,760
$52.10K
0.7%
CGEM Cullinan Therapeutics, Inc.
2 Sep 2021
Director
Sold, plan not stated
15,757
$464.20K
0.2%
CGEM Cullinan Therapeutics, Inc.
2 Sep 2021
Director
Sold, plan not stated
2,178
$64.16K
0.8%
CGEM Cullinan Therapeutics, Inc.
1 Sep 2021
Director
Sold, plan not stated
5,714
$168.39K
0.1%
CGEM Cullinan Therapeutics, Inc.
1 Sep 2021
Director
Sold, plan not stated
790
$23.28K
0.3%
CGEM Cullinan Therapeutics, Inc.
31 Aug 2021
Director
Sold, plan not stated
2,838
$84.62K
0.0%
CGEM Cullinan Therapeutics, Inc.
31 Aug 2021
Director
Sold, plan not stated
392
$11.69K
0.2%
CGEM Cullinan Therapeutics, Inc.
30 Aug 2021
Director
Sold, plan not stated
31,001
$908.33K
0.4%
CGEM Cullinan Therapeutics, Inc.
30 Aug 2021
Director
Sold, plan not stated
4,285
$125.55K
1.6%
CGEM Cullinan Therapeutics, Inc.
27 Aug 2021
Director
Sold, plan not stated
13,357
$388.56K
0.2%
CGEM Cullinan Therapeutics, Inc.
27 Aug 2021
Director
Sold, plan not stated
1,846
$53.70K
0.7%
CGEM Cullinan Therapeutics, Inc.
25 Aug 2021
Director
Sold, plan not stated
1,713
$49.83K
0.0%
CGEM Cullinan Therapeutics, Inc.
25 Aug 2021
Director
Sold, plan not stated
237
$6.89K
0.1%
CGEM Cullinan Therapeutics, Inc.
24 Aug 2021
Director
Sold, plan not stated
50,882
$1.50M
0.6%
CGEM Cullinan Therapeutics, Inc.
24 Aug 2021
Director
Sold, plan not stated
7,025
$207.10K
2.6%
CGEM Cullinan Therapeutics, Inc.
23 Aug 2021
Director
Sold, plan not stated
53,359
$1.55M
0.7%
CGEM Cullinan Therapeutics, Inc.
23 Aug 2021
Director
Sold, plan not stated
7,376
$214.72K
2.6%
CGEM Cullinan Therapeutics, Inc.
11 Aug 2021
Director
Sold, plan not stated
2,510
$72.92K
0.0%
CGEM Cullinan Therapeutics, Inc.
11 Aug 2021
Director
Sold, plan not stated
347
$10.08K
0.1%
HOWL Werewolf Therapeutics, Inc.
4 May 2021
10% owner
Bought
245,000
$3.92M
3.8%
CGEM Cullinan Therapeutics, Inc.
12 Jan 2021
Director
Bought
300,000
$6.30M
3.9%
VSTM Verastem, Inc.
1 Feb 2012
Director
Bought
96,260
$962.60K
5.0%
VSTM Verastem, Inc.
1 Feb 2012
Director
Bought
3,740
$37.40K
opened
70 decisions on file.